Kimia Biosciences Ltd

Ticker: KIMIABL
Risky 48/100

☆ Add to Watchlist

Investing Reference

Price
34.25
Market Cap
162.05
Debt/Equity
3.3163
ROE %
186.783
PB
16.2697
Promoter %
74.939
Pledge %
0.000
1Y Rev Growth %
12.880
5Y Rev Growth %
2.313
NP Margin %
7.992
NP Margin 5Y Avg %
-0.672

Trading Reference

1M Return %
-7.545
6M Return %
-13.793
1Y Return %
-31.156
% Away 52W High
153.577
% Away 52W Low
3.412
Daily Volume
4280
Investment Verdict
Avoid
Score 42/100 · Position size: 0%
Fundamentals/valuations or risk flags are weak. Avoid for long-term investing.
Trading Verdict
Avoid
Score 14/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Kimia Biosciences Ltd is currently trading near a key support level, with the 50-day EMA indicating potential upward momentum. However, resistance at recent highs may limit short-term gains. Overall, there is a moderate probability of price appreciation in the medium term, contingent on volume supporting upward movement.
Upside Probability: 25%   |   Downside Probability: 15%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Kimia Biosciences Ltd is a leading player in the Indian biotechnology sector, specializing in the development of innovative pharmaceutical solutions. Catering to healthcare providers and pharmaceutical companies, Kimia focuses on enhancing patient outcomes through cutting-edge research and development. Its commitment to quality and sustainability positions it as a trusted partner in the industry, making a significant impact on public health. With a robust pipeline of products and a dedicated team of experts, Kimia is poised for growth and innovation in the evolving healthcare landscape.

  • Leading biotechnology company in India
  • Focus on innovative pharmaceutical solutions
  • Enhances patient outcomes through R&D
  • Commitment to quality and sustainability
  • Trusted partner for healthcare providers
  • Strong pipeline for future growth

Investment Thesis

Kimia Biosciences Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's strategic positioning and robust fundamentals make it a promising choice for long-term investors.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Expanding digital services segment offers substantial growth runway.
  • Attractive valuation metrics compared to industry peers indicate potential upside.
  • Focus on innovation and R&D strengthens competitive advantage.
  • Positive market sentiment and growth outlook bolster investment appeal.

Opportunity vs Risk

Opportunities
  • Growing demand for biotech solutions
  • Strong pipeline of innovative products
  • Potential for strategic partnerships
  • Expansion into international markets
Risks ⚠️
  • Regulatory hurdles in biotech industry
  • High research and development costs
  • Market competition from established firms
  • Dependency on key patents and licenses

Peer Perspective

Kimia Biosciences Ltd trades at a discount to peers like Aarti Industries and Alkyl Amines, suggesting potential upside. A sustained improvement in margin stability could trigger a rerating in its valuation.

Future Outlook

Kimia Biosciences Ltd is well-positioned for growth, driven by innovative product pipelines and expanding market presence. Successful execution of strategic initiatives and effective cost control will be crucial in maximizing shareholder value.

AI FAQs for Retail Users

  • Q: What does Kimia Biosciences Ltd do?
    A: Kimia Biosciences Ltd focuses on developing and manufacturing pharmaceutical products and active pharmaceutical ingredients.
  • Q: Is Kimia Biosciences Ltd listed on Indian stock exchanges?
    A: Yes, Kimia Biosciences Ltd is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
  • Q: What are the key products of Kimia Biosciences Ltd?
    A: The company specializes in a range of pharmaceutical products, including generic medicines and APIs.
  • Q: How can I invest in Kimia Biosciences Ltd?
    A: You can invest through a brokerage account by purchasing shares on the stock exchanges.
  • Q: What are the risks of investing in Kimia Biosciences Ltd?
    A: As with any stock, risks include market volatility, regulatory changes, and company performance.
📊 Stock Investment Checklist (100 Points)
Kimia Biosciences Ltd • Updated: 2025-09-17 14:27:36
  • 10
    Business
    High
    The sector shows potential but lacks a strong competitive moat.
  • 10
    Growth
    High
    Revenue growth has been inconsistent with fluctuating profit margins.
  • 8
    Profitability
    High
    ROE and ROCE are below industry averages, cash flow is volatile.
  • 9
    Valuation
    High
    Valuation metrics are slightly above peers, indicating potential overvaluation.
  • 7
    Balance
    High
    Moderate debt levels but liquidity is a concern.
  • 6
    Governance
    Good
    Promoter holding is decent, but there are concerns about pledging.
  • 5
    Drivers
    Good
    Limited growth drivers identified, execution risks are high.
  • 1
    Technicals
    Low
    Weak market sentiment and low liquidity observed.
Final Score & Verdict
Score 48 / 100 • Risky
Kimia Biosciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 70/100
  • Growth Potential: 65/100
  • Profitability: 60/100
  • Governance: 75/100
  • Market Confidence: 68/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.